Leukaemia – a developmental perspective
- 12 May 2004
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 126 (1) , 3-10
- https://doi.org/10.1111/j.1365-2141.2004.04986.x
Abstract
Summary: Leukaemia is characterized by the accumulation of malignant haematopoietic precursors. Recent studies have revealed that acquired alterations in genes that regulate normal haematopoiesis are frequently detected in leukaemia. The progression to leukaemia depends on additional mutations that promote the survival of developmentally arrested cells. This review describes three examples of this general paradigm of leukaemogenesis: RUNX1 abnormalities in acute leukaemias, GATA1 mutations in the leukaemias of Down syndrome, and SCL and LMO2 ectopic expression in T cell acute lymphoblastic leukaemia.Keywords
This publication has 82 references indexed in Scilit:
- Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemiaBlood, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiationBlood, 2003
- Identification of RUNX1/AML1 as a classical tumor suppressor geneOncogene, 2003
- X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interactionBlood, 2002
- The TEL-AML1 Fusion Accompanied by Loss of the Untranslocated TEL Allele in B-Precursor Acute Lymphoblastic Leukaemia of ChildhoodLeukemia & Lymphoma, 2000
- Analysis of TEL proteins in human leukemiasOncogene, 1998
- Transcription factor GATA‐1 in megakaryocyte developmentThe International Journal of Cell Cloning, 1998
- The T Cell Leukemia Oncoprotein SCL/tal-1 Is Essential for Development of All Hematopoietic LineagesCell, 1996
- Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCLNature, 1995